Glucagon-like peptide 1 receptor agonist use is associated with reduced risk for glaucoma. Sterling J, Hua P, Dunaief JL, Cui QN, et al. Br J Ophthalmol 2021 Aug 19. pii: bjophthalmol-2021-319232.

Read + Share

Amedeo Smart

Independent Medical Education

Sterling J, Hua P, Dunaief JL, Cui QN, et al. Glucagon-like peptide 1 receptor agonist use is associated with reduced risk for glaucoma. Br J Ophthalmol 2021 Aug 19. pii: bjophthalmol-2021-319232.
PMID: 34413054